Detalhe da pesquisa
1.
Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies.
J Infect Dis
; 2023 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996072
2.
Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort.
J Viral Hepat
; 30(3): 232-241, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529681
3.
Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers.
Pharmacoepidemiol Drug Saf
; 32(4): 486-495, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444965
4.
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
Liver Int
; 42(1): 38-49, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520614
5.
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
BMC Infect Dis
; 22(1): 94, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086481
6.
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
J Hepatol
; 74(1): 37-47, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798585
7.
Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis.
HIV Med
; 22(10): 924-935, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34402547
8.
Effectiveness of direct-acting antivirals for chronic hepatitis C treatment in migrant and non-migrant populations in France.
Liver Int
; 41(10): 2328-2340, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590608
9.
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet
; 393(10179): 1453-1464, 2019 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765123
10.
Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort).
J Viral Hepat
; 27(12): 1473-1483, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810343
11.
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohort.
J Viral Hepat
; 27(10): 964-973, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436335
12.
Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategy.
J Viral Hepat
; 26(11): 1276-1283, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31273896
13.
The dynamic effect of direct-acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C.
J Viral Hepat
; 26(12): 1489-1492, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31386252
14.
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort.
BMC Infect Dis
; 19(1): 300, 2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30940090
15.
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
Blood
; 128(21): 2527-2532, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27605512
16.
Signal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infection.
Pharmacoepidemiol Drug Saf
; 27(7): 797-805, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29749668
17.
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.
J Hepatol
; 66(1): 39-47, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622858
18.
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Gastroenterology
; 147(1): 132-142.e4, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24704719
19.
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy.
Liver Int
; 35(7): 1833-44, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556540
20.
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Antimicrob Agents Chemother
; 58(9): 5332-41, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24982076